Centene Corp (CNC) stock
CNCNYSEHospital & Medical Service PlansFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 27, 2026Score 8/301% above fair value
$70.27−0.21 (-0.30%)
Close on Nov 12, 2026Market cap $34.79BP/E 24.1Yield –
Centene EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
Centene's EPS for the twelve months ending Sep 30, 2026 was $2.92. For fiscal 2025 it was -$13.53, down 314.4% from the year before. The highest annual figure on record is $6.31 in fiscal 2024.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$13.53 | -314.4% |
| FY2024 | Dec 31, 2024 | $6.31 | +27.5% |
| FY2023 | Dec 31, 2023 | $4.95 | +139.1% |
| FY2022 | Dec 31, 2022 | $2.07 | -9.2% |
| FY2021 | Dec 31, 2021 | $2.28 | -26.9% |
| FY2020 | Dec 31, 2020 | $3.12 | -0.6% |
| FY2019 | Dec 31, 2019 | $3.14 | +38.9% |
| FY2018 | Dec 31, 2018 | $2.26 | -3.4% |
| FY2017 | Dec 31, 2017 | $2.34 | +36.8% |
| FY2016 | Dec 31, 2016 | $1.71 | +18.8% |
| FY2015 | Dec 31, 2015 | $1.44 | +28.0% |
| FY2014 | Dec 31, 2014 | $1.13 | +53.1% |
| FY2013 | Dec 31, 2013 | $0.73 | +7250.0% |
| FY2012 | Dec 31, 2012 | $0.01 | -98.1% |
| FY2011 | Dec 31, 2011 | $0.53 | +12.8% |
| FY2010 | Dec 31, 2010 | $0.47 | -0.5% |
| FY2009 | Dec 31, 2009 | $0.47 | +0.5% |
| FY2008 | Dec 31, 2008 | $0.47 | – |
Quarterly eps
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$0.14 | – |
| Q2 FY2026 | Jun 30, 2026 | $2.19 | – |
| Q1 FY2026 | Mar 31, 2026 | $3.11 | +18.3% |
| Q4 FY2025 | Dec 31, 2025 | -$2.24 | -500.0% |
| Q3 FY2025 | Sep 30, 2025 | -$13.50 | -1092.6% |
| Q2 FY2025 | Jun 30, 2025 | -$0.51 | -123.6% |
| Q1 FY2025 | Mar 31, 2025 | $2.63 | +21.8% |
| Q4 FY2024 | Dec 31, 2024 | $0.56 | +600.0% |
| Q3 FY2024 | Sep 30, 2024 | $1.36 | +56.3% |
| Q2 FY2024 | Jun 30, 2024 | $2.16 | +12.5% |
| Q1 FY2024 | Mar 31, 2024 | $2.16 | +5.9% |
| Q4 FY2023 | Dec 31, 2023 | $0.08 | – |
| Q3 FY2023 | Sep 30, 2023 | $0.87 | -31.5% |
| Q2 FY2023 | Jun 30, 2023 | $1.92 | – |
| Q1 FY2023 | Mar 31, 2023 | $2.04 | +41.7% |
| Q4 FY2022 | Dec 31, 2022 | -$0.38 | -137.6% |
| Q3 FY2022 | Sep 30, 2022 | $1.27 | +28.3% |
| Q2 FY2022 | Jun 30, 2022 | -$0.29 | – |
| Q1 FY2022 | Mar 31, 2022 | $1.44 | +21.0% |
| Q4 FY2021 | Dec 31, 2021 | $1.01 | – |
| Q3 FY2021 | Sep 30, 2021 | $0.99 | +2.1% |
| Q2 FY2021 | Jun 30, 2021 | -$0.92 | -144.9% |
| Q1 FY2021 | Mar 31, 2021 | $1.19 | +1387.5% |
| Q4 FY2020 | Dec 31, 2020 | -$0.02 | -104.1% |
| Q3 FY2020 | Sep 30, 2020 | $0.97 | +321.7% |
| Q2 FY2020 | Jun 30, 2020 | $2.05 | +73.7% |
| Q1 FY2020 | Mar 31, 2020 | $0.08 | -93.5% |
| Q4 FY2019 | Dec 31, 2019 | $0.49 | -14.0% |
| Q3 FY2019 | Sep 30, 2019 | $0.23 | +360.0% |
| Q2 FY2019 | Jun 30, 2019 | $1.18 | +57.3% |
| Q1 FY2019 | Mar 31, 2019 | $1.24 | +29.2% |
| Q4 FY2018 | Dec 31, 2018 | $0.57 | -12.3% |
| Q3 FY2018 | Sep 30, 2018 | $0.05 | -91.4% |
| Q2 FY2018 | Jun 30, 2018 | $0.75 | +4.2% |
| Q1 FY2018 | Mar 31, 2018 | $0.96 | +146.2% |
| Q4 FY2017 | Dec 31, 2017 | $0.65 | -12.8% |
| Q3 FY2017 | Sep 30, 2017 | $0.58 | – |
| Q2 FY2017 | Jun 30, 2017 | $0.72 | – |
| Q1 FY2017 | Mar 31, 2017 | $0.39 | – |
| Q4 FY2016 | Dec 31, 2016 | $0.74 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?